EPO Patents = 2

Forward Citations = 21

Loading Chart...

1 inventor (with patents filed for the assignee):

Yun Long (9 out of 35 patents)

9 patents: Sort by Forward Citations

1. 11787788 - Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof (2023-10-17),

2. 11713322 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2023-08-01),

3. 11427565 - Benzimidazoles for use in the treatment of cancer and inflammatory diseases (2022-08-30),

4. 11242352 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2022-02-08),

5. 10683304 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2020-06-16),

6. 10647707 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2020-05-12),

7. 10590108 - Benzimidazoles for use in the treatment of cancer and inflammatory diseases (2020-03-17),

8. 10202398 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2019-02-12),

9. 10005765 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2018-06-26),

Company Overview

Capella Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for rare and genetic diseases. With a strong pipeline of innovative treatments, Capella Therapeutics is dedicated to improving the lives of patients worldwide. Combining cutting-edge science with a passion for healthcare, the company is committed to advancing precision medicine and personalized therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#580 in San Diego, CA

#7,745 in California

#32,605 in US

San Diego, CA, United States of America

Capella Therapeutics, Inc.

Forward Citations = 21

1 inventor:

Yun Long (9 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Capella Therapeutics, Inc.. Retrieved from https://idiyas.com/company/capella-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]